US74291D1046
US74291D1046
ProKidney Corp.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 694.58M EUR | 419.66M EUR | 254.15M EUR | 317.65M EUR |
Enterprise Value | 1.28B EUR | 348.32M EUR | 156.03M EUR | 213.15M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -2.97x | -- | -- | -- |
Price to Sales | 849.12x | 513.03x | 285.88x | 479.11x |
Price to Book | -- | -- | -- | -- |
EV/Revenue | 1,558.86x | 425.81x | 175.52x | 321.49x |
EV/EBITDA | -7.49x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -12.07% | -38.06% | -59.04% | -32.93% |